Clinical

Respiratory: synthetic iron compounds could stifle tuberculosis

A team of researchers from Spain and South America have synthesised two iron compounds that inhibit the in vitro growth of Mycobacterium tuberculosis, the bacterium that causes tuberculosis. Due to their low level of toxicity in mammal cells, the compounds could be used in the future as therapeutic agents and hospital disinfectants, say scientists.

A group from the Universidad de Navarra in Spain, the Universidad de la República in Uruguay, the Universidad de São Paulo in Brazil, and the Universidad Nacional de La Plata in Argentina have synthesised two iron complexes “that showed in vitro growth inhibitory activity on Mycobacterium tuberculosis”.

Read more.

Bookmark and Share

Post a Comment

Enter this security code

Submit Comment for Moderation